RACCNasdaqPharmaceutical PreparationsUS GAAP · USD

Research Alliance Corp III

Research Alliance Corp III is a blank check company formed to complete a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination. It does not operate an underlying commercial business and instead serves as a public acquisition vehicle that holds IPO proceeds while searching for a target company.

Business

Share of revenue
SPAC vehicle100 %

A public shell company formed to acquire or merge with an operating business.

Customers

The company does not sell products or services to end customers in the ordinary course. Its counterparties are the investors, sponsor, and potential merger targets involved in the search for and execution of an initial business combination.

Public shareholders

Invest in the SPAC units and Class A shares to gain exposure to a future acquisition transaction.

Sponsor and affiliates

Provide formation capital, working capital support, and transaction-related loans.

Private placement investors

Buy private placement shares alongside the IPO to support the trust structure.

Potential target businesses

Are evaluated as merger or acquisition candidates for the initial business combination.

Strategy

The company’s core strategy is to identify and complete an initial business combination using IPO proceeds, private placement capital, and permitted financing sources. Its value proposition depends on sourcing an attractive target, negotiating terms, and closing a transaction within the SPAC framework.

Source and evaluate target businessesShort term

The company has no operating business until it completes a combination.

Close an initial business combinationShort term

Completion of a transaction is the central objective of the SPAC structure.

Maintain transaction funding capacityShort term

Working capital and deal costs must be covered before a target is acquired.

Geography

Research Alliance Corp III is incorporated in the Cayman Islands, while its securities and capital-raising activity are tied to the U.S. public markets. Because it is a blank check company, its eventual operating geography will depend on the business it acquires.

Risks

The company’s main risk is that it may not identify, negotiate, or complete a business combination, which would leave it without an operating business. It also faces the typical SPAC risks of shareholder redemptions, transaction financing uncertainty, and ongoing public-company compliance costs before any acquisition closes.

Sorted by severity
Failure to complete an initial business combinationCritical

The company exists solely to acquire a target business and has no operating revenue base.

Exposure: Entire business model

Insufficient transaction fundingHigh

Deal costs and working capital may exceed cash held outside the trust account.

Exposure: Sponsor loans and offering proceeds

Shareholder redemptionsHigh

Redemptions can reduce the cash available to fund the acquisition and post-close operations.

Exposure: Trust account proceeds

Public company compliance burdenMedium

Legal, accounting, audit, and reporting obligations create ongoing expenses before any acquisition.

Exposure: Pre-combination period

Accounting

Judgemental items
Trust account accounting

IPO proceeds are held in trust and affect liquidity, redemption value, and transaction funding.

Impact: Determines cash available for the business combination

Offering costs and deferred underwriting commissions

These costs reduce net proceeds and are material in a SPAC structure.

Impact: Affects equity and transaction economics

Sponsor and working capital loans

Related-party funding may need separate presentation and disclosure.

Impact: Affects liabilities and liquidity analysis

Pre-combination expense recognition

Formation, legal, and public-company costs are recognized before any operating revenue exists.

Impact: Drives reported losses in the pre-deal period

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026